S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

LifeMD (LFMD) Stock Forecast, Price & News

-0.03 (-1.44%)
(As of 05/20/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
85,100 shs
Average Volume
177,180 shs
Market Capitalization
$63.13 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive LFMD News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

LifeMD logo

About LifeMD

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.


See More Headlines

Industry, Sector and Symbol

Offices & clinics of medical doctors
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$92.88 million
Book Value
$0.39 per share


Net Income
$-60.90 million
Pretax Margin




Free Float
Market Cap
$63.13 million

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

2.24 out of 5 stars

Medical Sector

331st out of 1,416 stocks

Offices & Clinics Of Medical Doctors Industry

4th out of 13 stocks

Analyst Opinion: 3.5Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -

LifeMD (NASDAQ:LFMD) Frequently Asked Questions

Is LifeMD a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifeMD in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LifeMD stock.
View analyst ratings for LifeMD
or view top-rated stocks.

When is LifeMD's next earnings date?

LifeMD is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for LifeMD

How were LifeMD's earnings last quarter?

LifeMD, Inc. (NASDAQ:LFMD) posted its earnings results on Monday, March, 7th. The company reported ($0.29) EPS for the quarter, topping analysts' consensus estimates of ($0.39) by $0.10. The business had revenue of $27.42 million for the quarter, compared to the consensus estimate of $27.45 million. LifeMD had a negative net margin of 60.35% and a negative trailing twelve-month return on equity of 2,115.32%.
View LifeMD's earnings history

What guidance has LifeMD issued on next quarter's earnings?

LifeMD issued an update on its second quarter 2022 earnings guidance on Friday, May, 20th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $31.00 million-$33.00 million, compared to the consensus revenue estimate of $34.58 million.

What price target have analysts set for LFMD?

2 brokerages have issued 1-year price targets for LifeMD's stock. Their forecasts range from $8.00 to $14.00. On average, they expect LifeMD's share price to reach $10.00 in the next year. This suggests a possible upside of 387.8% from the stock's current price.
View analysts' price targets for LifeMD
or view top-rated stocks among Wall Street analysts.

Who are LifeMD's key executives?
LifeMD's management team includes the following people:
  • Mr. Justin Schreiber, CEO & Chairman (Age 39, Pay $225k) (LinkedIn Profile)
  • Mr. Brad Michael Roberts, Chief Operating Officer (Age 41, Pay $75k)
  • Mr. Eric H. Yecies, Chief Compliance Officer & Gen. Counsel (Age 43, Pay $29.77k)
  • Mr. Stefan Galluppi, Chief Innovation & Marketing Officer and Director (Age 35, Pay $165k) (LinkedIn Profile)
  • Mr. Nicholas P. Alvarez, Chief Acquisition Officer & Head of Customer Acquisition (Age 29, Pay $141.11k)
  • Mr. Bryant Patrick Hussey, Chief Digital Officer (Age 45, Pay $40k)
  • Mr. Alexander Mironov, Pres
  • Mr. Marc Benathen, Chief Financial Officer (Age 41)
  • Ms. Maria E. Stan CPA, Controller & Principal Accounting Officer
  • Mr. Dennis Wijnker, Chief Technology Officer
What is LifeMD's stock symbol?

LifeMD trades on the NASDAQ under the ticker symbol "LFMD."

Who are LifeMD's major shareholders?

LifeMD's stock is owned by many different retail and institutional investors. Top institutional investors include B. Riley Financial Inc. (3.89%), Vanguard Group Inc. (2.63%), Granahan Investment Management LLC (0.96%), GSA Capital Partners LLP (0.48%), State Street Corp (0.24%) and Wealthspire Advisors LLC (0.20%). Company insiders that own LifeMD stock include Bertrand Velge, Brad Michael Roberts, Corey Deutsch, Eric Harold Yecies, Happy David Walters, Joseph Ditrolio, Justin Schreiber, Marc David Benathen, Naveen Bhatia and Stefan Galluppi.
View institutional ownership trends for LifeMD

Which major investors are selling LifeMD stock?

LFMD stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Anchor Capital Advisors LLC, and Goldman Sachs Group Inc..
View insider buying and selling activity for LifeMD
or view top insider-selling stocks.

Which major investors are buying LifeMD stock?

LFMD stock was bought by a variety of institutional investors in the last quarter, including Granahan Investment Management LLC, GSA Capital Partners LLP, Wealthspire Advisors LLC, B. Riley Financial Inc., Group One Trading L.P., State Street Corp, and Simplex Trading LLC. Company insiders that have bought LifeMD stock in the last two years include Bertrand Velge, Brad Michael Roberts, Corey Deutsch, Eric Harold Yecies, Happy David Walters, Joseph Ditrolio, Justin Schreiber, Marc David Benathen, Naveen Bhatia, and Stefan Galluppi.
View insider buying and selling activity for LifeMD
or or view top insider-buying stocks.

How do I buy shares of LifeMD?

Shares of LFMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LifeMD's stock price today?

One share of LFMD stock can currently be purchased for approximately $2.05.

How much money does LifeMD make?

LifeMD has a market capitalization of $63.13 million and generates $92.88 million in revenue each year. The company earns $-60.90 million in net income (profit) each year or ($2.260010) on an earnings per share basis.

How many employees does LifeMD have?

LifeMD employs 196 workers across the globe.

What is LifeMD's official website?

The official website for LifeMD is www.lifemd.com.

How can I contact LifeMD?

LifeMD's mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The company can be reached via phone at (866) 351-5907 or via email at [email protected].

This page was last updated on 5/23/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.